Statistics
Publications
35
Citations
3.7K
H-Index
25
Active since
1997
Thomas C. Mitchell is an author at University of Louisville specializing in immunology, life sciences, and innate immunity.
Publications per year
1997–2023
35
35
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Verónica Mata‐Haro, Caglar Cekic, Michael Martin et al. · Science · 2007 · 891 citations
Activated T Cell Death In Vivo Mediated by Proapoptotic Bcl-2 Family Member Bim
David A. Hildeman, Yanan Zhu, Thomas C. Mitchell et al. · Immunity · 2002 · 558 citations · Full text
Immunological adjuvants promote activated T cell survival via induction of Bcl-3
Thomas C. Mitchell, David A. Hildeman, Ross M. Kedl et al. · Nature Immunology · 2001 · 223 citations
T cell apoptosis and reactive oxygen species
David A. Hildeman, Thomas C. Mitchell, John W. Kappler et al. · Journal of Clinical Investigation · 2003 · 152 citations · Full text
1–5 of 35